Syneos Health Wins 2023 ViE Award
05 avr. 2023 07h30 HE
|
Syneos Health, Inc.
MORRISVILLE, N.C., April 05, 2023 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), a leading fully integrated biopharmaceutical solutions organization, today announced it has been awarded...
Syneos Health Names Jeanine O’Kane as Communications President
04 avr. 2023 14h05 HE
|
Syneos Health, Inc.
MORRISVILLE, N.C., April 04, 2023 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq: SYNH), a leading fully integrated biopharmaceutical solutions organization, today announced Jeanine O’Kane as President...
Syneos Health Launches Medical Affairs Digital Amplifier
27 mars 2023 07h30 HE
|
Syneos Health, Inc.
MORRISVILLE, N.C., March 27, 2023 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq: SYNH), a leading fully integrated biopharmaceutical solutions organization, today announced the launch of Medical...
Syneos Health and KX Partner to Pioneer Data-Driven Transformation in Biopharmaceutical Asset Development
22 mars 2023 07h30 HE
|
Syneos Health, Inc.
MORRISVILLE, N.C., March 22, 2023 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), a leading fully integrated biopharmaceutical solutions organization, today announced a strategic partnership with...
Syneos Health Collaborates with Microsoft to Accelerate AI Across the Clinical to Commercial Continuum
20 mars 2023 06h45 HE
|
Syneos Health, Inc.
MORRISVILLE, N.C., March 20, 2023 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), a leading fully integrated biopharmaceutical solutions organization, today announced a strategic multi-year...
Syneos Health Unveils New Decentralized Clinical Trial Site Network to Drive DCT Adoption
28 févr. 2023 07h30 HE
|
Syneos Health, Inc.
MORRISVILLE, N.C., Feb. 28, 2023 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq: SYNH), a leading fully integrated biopharmaceutical solutions organization, today announced the launch of a Decentralized...
Syneos Health Reports Fourth Quarter and Full Year 2022 Results
16 févr. 2023 06h03 HE
|
Syneos Health, Inc.
Revenue for the fourth quarter of $1,359.9 million decreased 1.0% on a reported basis and increased 1.7% on a constant currency basis year-over-year.Clinical Solutions net new business awards and...
Syneos Health Schedules Fourth Quarter and Full Year 2022 Earnings Call for Thursday, February 16th, 2023
08 févr. 2023 21h41 HE
|
Syneos Health, Inc.
MORRISVILLE, N.C., Feb. 08, 2023 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, will release its fourth quarter and full year...
Syneos Health Partners with Equicare, Optimizing Data Capture and Integration to Accelerate Clinical Trial Research
08 févr. 2023 07h30 HE
|
Syneos Health, Inc.
MORRISVILLE, N.C., Feb. 08, 2023 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced a strategic partnership with...
Syneos Health and Haystack Health Partner to Accelerate Clinical Trials with AI
07 févr. 2023 07h30 HE
|
Syneos Health, Inc.
MORRISVILLE, N.C., Feb. 07, 2023 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq: SYNH), the only fully integrated biopharmaceutical solutions organization, today announced a strategic partnership with...